Northern Biologics Inc. Company
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Canada
Founded Date:
2014
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
3
Total Funding:
$20.7M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership